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Abstract: Coenzyme A (CoA) and acetyl-coenzyme A (acetyl-CoA) play essential roles in cell
energy metabolism. Dysregulation of the biosynthesis and functioning of both compounds may
contribute to various pathological conditions. We describe here a simple and sensitive HPLC-UV
based method for simultaneous determination of CoA and acetyl-CoA in a variety of biological
samples, including cells in culture, mouse cortex, and rat plasma, liver, kidney, and brain tissues.
The limits of detection for CoA and acetyl-CoA are >10-fold lower than those obtained by previously
described HPLC procedures, with coefficients of variation <1% for standard solutions, and 1–3%
for deproteinized biological samples. Recovery is 95–97% for liver extracts spiked with Co-A
and acetyl-CoA. Many factors may influence the tissue concentrations of CoA and acetyl-CoA
(e.g., age, fed, or fasted state). Nevertheless, the values obtained by the present HPLC method for the
concentration of CoA and acetyl-CoA in selected rodent tissues are in reasonable agreement with
literature values. The concentrations of CoA and acetyl-CoA were found to be very low in rat plasma,
but easily measurable by the present HPLC method. The method should be useful for studying
cellular energy metabolism under normal and pathological conditions, and during targeted drug
therapy treatment.
Keywords: Acetyl-coenzyme A; coenzyme A; high performance liquid chromatography; UV detection

1. Introduction
Coenzyme A (CoA) and acetyl-coenzyme A (acetyl-CoA) are involved in a number of important
biochemical reactions in the cell. For example, they play essential roles in epigenetics, signaling, and
in the metabolism of carbohydrates, lipids, amino acids, and ketone bodies [1–6]. Cellular levels of
CoA and acetyl-CoA may fluctuate significantly under conditions of fasting/feeding, in response to
nutrients and hormones, during energetic stress, and/or cell growth [6–8]. Acetyl-CoA is a crucial
metabolic intermediate, the concentration of which reflects the general energetic state of the cell.
The concentration of acetyl-CoA influences the specificity/activity of multiple enzymes and contributes
to the control of key cellular processes, including energy metabolism, mitosis, and autophagy [5].
Specifically, acetyl-CoA operating as a metabolic intermediate and as a second messenger determines
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the balance between cellular catabolism and anabolism [5]. Of particular significance, acetyl-CoA
is critically important in regulating the synthesis and degradation of pyruvate [1,5]. CoA levels in
tissues are tightly regulated and depend on a number of nutritional conditions that help to maintain
glucose homoeostasis [1,6,7]. For example, the biosynthesis of CoA is controlled in part by the activity
of the isoenzymes (isoforms) pantothenate kinase 1 and pantothenate kinase 2 (PanK1 and PanK2).
Mutations of the PanK1 and PanK2 genes are associated with PanK-dependent neurodegeneration
(PKAN) and diabetes [1,9]. It has been suggested that the development of modulators of PanK activity
represent a promising approach to the treatment of both PKAN and diabetes [10]. Thus, a simple and
reliable method for simultaneous measurement of CoA and acetyl-CoA in biological samples would
be helpful to researchers studying diabetes and certain rare genetic neurodegenerative diseases.
Many methods have been published for the measurement of CoA and acetyl-CoA in biological
samples, including radiochemical methods, spectrophotometric/fluorometric enzyme cycling methods,
high-performance liquid chromatography (HPLC), high-performance capillary electrophoresis (HPCE),
and mass-spectrometry (MS) [11–17]. Kits are also commercially available for the fluorometric
determination of acetyl-CoA (e.g., Sigma-Aldrich, Saint Louis, MO, USA) and CoA (e.g., Abcam,
Cambridge, MA, USA). Each method has certain advantages, but also restrictions and concerns due to
the limited analysis sensitivity and/or complexity. For example, advanced LC-MS/MS techniques for
the measurement of CoA and acetyl-CoA are highly sensitive [16], but also are more expensive to use.
Increased costs include, but are not limited to, yearly services, maintenance, repair, and high operator
salary costs. Therefore, LC-MS/MS technique is not cost effective for multiple, routine analyses under
regular laboratory settings. Despite some concerns regarding the complexity of sample preparation,
disposal of potentially hazardous effluents, and the possible unsuitability for high-throughput analyses,
HPLC methods for determination of acetyl-CoA and CoA have proved to be useful in a variety of
biological settings [17–21].
Shibata and co-workers have introduced an especially simple and useful HPLC-based method for
the simultaneous measurement of tissue CoA and acetyl-CoA (and dephospho-CoA) [21]. The limit
of detection for the method is ~10 pmol per injectate for each of the three analytes. The procedure
published by Shibata and co-workers appears to be more sensitive than those of previously published
HPLC methods, but is less sensitive than MS-based techniques [16,20,21]
In the present work we describe an HPLC procedure for the determination of CoA and acetyl-CoA
in a variety of biological samples. We used as a starting point our previous method for the HPLC
separation of tricarboxylic acid (TCA) cycle intermediates [22]. Our procedure results in faster HPLC
separation and higher sensitivity than previous HPLC methods. Indeed, the sensitivity of the present
procedure is comparable to that obtained by MS measurements. Moreover, it was shown that there
is no co-elution or interference by other metabolites in the biological samples analyzed. To illustrate
the suitability of the present HPLC-based method for CoA and acetyl-CoA analysis in biological
samples, we measured the levels of these metabolites in a variety of biological samples, namely cells
in culture, mouse brain cortex, as well as in rat plasma, and rat tissues (liver, kidney, and brain).
The results obtained by the present procedure are in general agreement with literature values.
2. Materials and Methods
2.1. Chemicals
All solutions were prepared in Millipore water (Milli-Q system, Billerica, MA, USA). Aqueous
solutions (72%) of perchloric acid (PCA) and HPLC grade acetonitrile were obtained from JT
Baker (Phillipsburg, NJ, USA); the trilithium salt of acetyl-CoA, the sodium salt hydrate of CoA,
sodium acetate, monosodium phosphate, 85% aqueous phosphoric acid, oxaloacetic acid, citrate
synthase (from porcine heart; ammonium sulfate suspension; >1000 U/mg), acetyl phosphate,
Tris HCl, and dithiothreitol (DTT) were obtained from Sigma Aldrich (Saint Louis, MO, USA);
phosphotransacetylase (lyophilized preparation from Bacillus stearothermophilus, ~1000 U/mg solid)
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was obtained from Boehringer Mannheim (Ridgefield, CT, USA); Dulbecco Modified Eagle’s Medium
(DMEM) was obtained from VWR Life Sciences (Radnor, PA, USA); fetal bovine serum (FBS) was
obtained from Gemini Bio-Products (West Sacramento, CA, USA); and, the Bio-Rad DC™ protein
assay kit was obtained from Bio-Rad (Hercules, CA, USA). Nylon membrane filters with a diameter
of 47 mm and a pore size of 0.2 µm that were used for mobile phase filtering and degassing were
obtained from Pall Life Science (Port Washington, NY, USA).
2.2. Standard Stock Solutions
Standard stock solutions of CoA and acetyl-CoA (1–10 mM) were prepared in deionized water.
Sets of CoA and acetyl-CoA standards were obtained by serial dilutions of stock solutions of
the standards in 5% aqueous PCA. These standard stock solutions of CoA and acetyl-CoA were
stable at −80 ◦ C for a minimum of two years.
2.3. HPLC System
For our most effective HPLC analysis procedure we used Waters instruments (Milford, MA, USA),
1525 binary pump, 2707 autosampler with pre-cooled platform (4 ◦ C), and a 2489 UV/VIS detector.
Data collection and data analysis were aided by Breeze2 software (Waters Corp, Milford, MA, USA)
installed on a Dell computer. The wavelength for UV detection was set at 259 nm. Separation of CoA
from acetyl-CoA was achieved with an ESA Inc. (now Dionex & Thermo Fisher Scientific Company,
Bedford, MA, USA) RP-C18, 150 × 3 mm, 3 µm, 120 Å (PN# 70-0636) analytical column equipped with
a Phenomenex Security Guard column (Torrance, CA, USA), cartridge C18, 4 × 2 mm, (PN# AJ0-4286).
The columns were maintained at room temperature, the flow rate was 0.5 mL/min, and the injection
volume was 30 µL. Under these conditions CoA and acetyl-CoA elute at 3.8 and 7.8 min, respectively.
The HPLC run for both metabolites is completed within 12 min without any additional time for column
re-equilibration between the HPLC runs.
2.4. Mobile Phase
To minimize the possibility of baseline drift, an isocratic mobile phase at constant room
temperature was used in the present work. The mobile phase was as described by Shibata and
coauthors [21], and consisted of 100 mM monosodium phosphate and 75 mM sodium acetate. The pH
was adjusted to 4.6 with concentrated phosphoric acid. Acetonitrile was added to the prepared mobile
phase at a ratio of 6 (acetonitrile) to 94 (mobile phase) (v/v). Prior to HPLC analysis, the freshly
prepared mobile phase was filtered and degassed (see Section 2.1 for details).
2.5. Preparation of Biological Samples for HPLC Analysis
2.5.1. Cell Cultures
CoA and acetyl-CoA concentrations were measured in cytoplasmic hybrid cells (cybrids; herein
referred to as mtDNA mutant cells) harboring a patient-derived T8993G mitochondrial DNA (mtDNA)
mutation, and compared with progenitor cells harboring wild type (WT) mtDNA (143B osteosarcoma cell
line). The T8993G mutation, which is in subunit 6 of ATPase (ATP6), is associated with neuropathy, ataxia,
and retinitis pigmentosa (NARP), or fatal childhood maternally inherited Leigh’s syndrome (MILS) [23].
The mutant cell line we used has 30% residual ATP synthesis activity and 60% residual respiration [23].
The mutant and WT cells were cultured in 10-cm Petri dishes at 37 ◦ C, and 5% CO2 with 10 mL
of DMEM containing 4.5 mg/mL glucose, 1 mM pyruvate, 4 mM glutamine, supplemented with 5%
FBS, and 50 µg/mL of uridine. The cells were incubated for two days before the HPLC measurements,
and achieved a density of approximately 1.5–1.7 million cells per Petri dish. Adherent cells were
trypsinized, transferred into 15-mL centrifuge tubes, and centrifuged at 1000× g for 3 min at 4 ◦ C.
The sedimented cell pellet was washed once with 1 mL of phosphate buffered saline, and centrifuged
at 1000× g for 5 min at 4 ◦ C. The resulting pellet was resuspended in 0.3 mL of aqueous 5% PCA
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solution containing 50 µM DTT. The cell suspension was transferred into a 1.5-mL Eppendorf tube,
incubated on ice for 10 min, vortexed several times, and centrifuged at 14,000× g for 10 min at 4 ◦ C.
The supernatant was removed and immediately analyzed by HPLC. The concentration of CoA and
acetyl-CoA in the sample was calculated as nmol per mg of protein using the corresponding calibration
curve. The pellet was resuspended in 0.3 mL of 0.1 M NaOH and used for protein measurements.
2.5.2. Mouse Cerebral Cortex
CoA and acetyl-CoA were determined in cerebral cortices derived from 9–10-months-old WT and
Mutant (Mut) mice. The Mut mice express a mutated form of mtDNA polymerase gamma (Polg) that
results in mtDNA with a high burden of somatic mutations [24]. The Mut mice are a useful model
for studies of age-related neurodegenerative diseases associated with mitochondrial dysfunction [24],
such as Alzheimer disease and Parkinson disease. These mice are also a good model for studying
the beneficial effects of physiological activity (exercise) in neurodegeneration, and for preclinical
assessment of possible therapeutic interventions [24,25].
Both groups of mice (n = 6) were euthanized by cervical dislocation followed by decapitation.
(The care of these experimental animals conformed to the guidelines for the ethical treatment of
laboratory animals set by the McMaster University Animal Care and Use Committee and the Beth
Israel Deaconess Medical Center Animal Care and Use Committee). The brains were quickly removed
and each isolated brain was placed into ice-cold sterile saline, and dissected as described previously [24].
Briefly, the brain was placed into a chilled Brain Matrix, designed for freehand slicing of discrete
regions of the brain (World Precision Instruments, RBMA-200C, Sarasota, FL, USA), cut into 1 mm thick
coronal sections on wet ice, and then snap-frozen in liquid nitrogen. To 2–9 mg of the frozen cortex
was added 200 µL of ice-cold aqueous 5% PCA, supplemented with 50 µM DTT. The mixture was
then vortexed and homogenized by brief sonication for 6 s at amplitude 15%. During the sonication
period, and for 10–15 min thereafter, the samples were kept on ice and periodically vortexed for 10 s
every 2–3 min for maximal metabolite extraction. The homogenates were centrifuged at 14,000× g for
10 min at 4 ◦ C. The protein-free supernatant was centrifuged once again under the same conditions,
and a 100-µL aliquot was transferred into an HPLC vial for direct injection into the HPLC system.
The concentrations of CoA and acetyl-CoA in the sample were calculated as µmol per g of wet tissue
using the corresponding calibration curves.
2.5.3. Rat Tissues
Four-month old female outbred Wistar rats (130–140 g weight) were euthanized by decapitation.
(The care of these experimental animals conformed to the guidelines for the ethical treatment of laboratory
animals set by the Institutional Review Board at the Bach Institute of Biochemistry). Tissue samples
were rapidly excised and immediately frozen in liquid nitrogen. Ice-cold aqueous 5% PCA (200 µL)
containing 50 µM DTT was added to the frozen brain, liver or kidney tissue sample (10–20 mg), vortexed
and homogenized by brief sonication for 12 s at amplitude 20%. The rat tissues were processed as
described above for mouse cerebral cortex. The concentrations of CoA and acetyl-CoA in the sample
were calculated as nmol per mg of protein using the corresponding calibration curves.
2.5.4. Rat Plasma
Each rat plasma sample (50 µL) was separately added to a tube containing 250 µL of ice-cold
aqueous 5% PCA, supplemented with 50 µM DTT. The acid-treated extract was vortexed, centrifuged,
and processed as described above. The concentrations of CoA and acetyl-CoA in the plasma samples
were calculated using the corresponding calibration curves.
2.5.5. Treatment of Neutralized Tissue Extracts with Citrate Synthase (CS)
In some experiments, neutralized PCA extracts were treated with CS to ensure that the HPLC peak
assigned to acetyl-CoA is due entirely to acetyl-CoA, and contained no UV-absorbing compound(s)
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that elute(s) with the same retention time (RT) as that of acetyl-CoA [20]. CS catalyzes the following
reaction (Equation (1)):
Acetyl-CoA + oxaloacetate  CoA + citrate
(1)
To 50 µL of PCA-treated rat liver extract neutralized with a minimal amount of 2 M K2 CO3 (final
pH 7.4), followed by the removal of insoluble potassium perchlorate by centrifugation, was added
10 µL of 1 M Tris buffer (pH 7.4), 5 µL of freshly prepared 10 mM oxaloacetate, 25 µL of deionized
water, and 10 µL of a solution of CS (~94 U/mL, dissolved in deionized water). The resulting reaction
mixture was incubated for ~5 min at 37 ◦ C, and a 50-µL aliquot was transferred directly into a vial for
immediate HPLC-UV analysis.
2.5.6. Treatment of Neutralized Tissue Extracts with Phosphotransacetylase (PTA)
In some experiments, neutralized PCA extracts were treated with PTA to ensure that the HPLC
peak assigned to CoA is due entirely to CoA, and contained no UV-absorbing compound(s) that elute(s)
with the same RT value as CoA [20]. PTA catalyzes the following reaction (Equation (2)):
CoA + acetyl phosphate  acetyl-CoA + Pi

(2)

To 50 µL of PCA-treated rat liver extract, neutralized with the minimal amount of 2 M K2 CO3
(pH 7.4), followed by the removal of insoluble potassium perchlorate by centrifugation, was added
20 µL of 1 M Tris buffer (pH 7.4), 20 µL of 10 mM acetyl phosphate, and 10 µL of a solution of PTA
(~100 U/mL, dissolved in deionized water). The mixture was incubated for ~5 min at 37 ◦ C and
a 50-µL aliquot was transferred into a vial for immediate HPLC-UV analysis. It should be noted
that although the reaction is freely reversible, the backward direction of Equation (2) is favored [26].
Thus, a large excess of acetyl phosphate over the expected concentration of CoA in the tissue sample
is required to ensure complete removal of CoA. Moreover, Tris was chosen as a buffer rather than
phosphate, because phosphate is a product inhibitor of the forward reaction [26].
2.6. Protein Analysis
For protein measurements a standard Bio-Rad DC™ protein assay kit (cat#500-0113, 500-0114,
500-1115) was used. Pellets obtained from deproteinized tissue/plasma samples were dissolved by brief 10 s
vortexing in 0.5 mL of 0.1 M NaOH. For protein analysis a six fold dilution of the suspension in deionized
water was used. Protein concentration was measured spectrophotometrically, using a SpectraMax M5
platereader (Molecular Devises, Sunnyvale, CA, USA) set at a wavelength of 670 nm.
2.7. Statistical Analysis
Data are presented as the Average ± the Standard Deviation; p values were determined by
the two tailed paired t test.
3. Results
3.1. Measurement of CoA and Acetyl-CoA in Combined Standard Solutions by HPLC
Using the HPLC conditions described in the Materials and Methods section, we were able to
accurately quantify CoA and acetyl-CoA in standard solutions. Representative chromatograms for
combined CoA and acetyl-CoA standards are shown in Figure 1A. Calibration curves for CoA and
acetyl-CoA standards were shown to be linear over the entire concentration range from 0 to 1 mM
(data not shown). Only the calibration plots at the physiologically relevant range of 0–5 µM for
both CoA and acetyl-CoA are shown (Figure 1B,C, respectively). Values for the peak height for each
sample were plotted against known concentrations of individual standards. The equations of the
linear regressions for the resulting plots (shown in panels B and C) were used to determine CoA and
acetyl-CoA concentrations in the sample.

example, Shibata et al. [21] reported an LOD of ~10 pmol per injectate for both CoA and acetyl-CoA.
By contrast, the LOD for CoA and acetyl-CoA, obtained by the present procedure are 0.0038 and 0.012
µM, respectively, or 0.114 and 0.36 pmol per injectate, respectively. The increase in sensitivity of our
procedure, when compared to that of previous HPLC procedures may be due to the high sensitivity
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Having established that CoA and acetyl-CoA are well separated by our HPLC system, we next
determined whether the procedure is applicable to biological samples. This was found to be the case.
Individual concentrations of CoA and acetyl-CoA in these samples were normalized either to protein
content (nmol per mg of protein) or to µmol per g of tissue wet weight. The coefficient of variation
(CV, %, n = 3) for CoA and acetyl-CoA measurements in the standards was <1%. The CVs for CoA and
acetyl-CoA measurements in the biological samples were within 1–3%. The recovery was determined
by addition of known amounts of CoA and acetyl-CoA to the frozen tissue sample simultaneously with
addition of the PCA deproteinizing agent. After extraction with the PCA reagent, and the removal of
precipitated protein by centrifugation, the recovery for both metabolites was within 95–97%. The CoA
and acetyl-CoA in the prepared sample extracts were stable at 4 ◦ C for at least 24 h after preparation.
The limit of detection (LOD) of our procedure is one to almost two orders of magnitude more sensitive
than that described for previous HPLC methods [19–21]. For example, Shibata et al. [21] reported
an LOD of ~10 pmol per injectate for both CoA and acetyl-CoA. By contrast, the LOD for CoA and
acetyl-CoA, obtained by the present procedure are 0.0038 and 0.012 µM, respectively, or 0.114 and
0.36 pmol per injectate, respectively. The increase in sensitivity of our procedure, when compared to
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Table 1. Concentrations of CoA and acetyl-CoA in different biological samples a .
Biological Sample
b

WT cells
Mut cells b
WT mouse cortex c
Mut mouse cortex c
Rat liver b
Rat kidney b
Rat brain b
Rat plasma d
a

N
6
6
6
6
16
16
16
16

CoA
0.467 ± 0.015
0.040 ± 0.001 e
0.017 ± 0.006
0.012 ± 0.004
0.872 ± 0.122
0.191 ± 0.062
0.079 ± 0.024
0.009 ± 0.001

Acetyl-CoA
0.162 ± 0.004
0.140 ± 0.009 f
0.008 ± 0.003
0.005 ± 0.001
0.194 ± 0.038
0.013 ± 0.006
0.028 ± 0.011
0.0003 ± 0.0001

Data are Average ± Standard Deviation. The concentrations are expressed in: b nmol/mg protein, c µmol/g wet
tissue, d µM. e Different from the value obtained for the WT cells with p < 0.001. f Different from the value obtained
for the WT cells with p < 0.005. WT, wild type; Mut, mtDNA mutant.
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4. Discussion
4.1. WT and mtDNA Mutant Cells
As noted in the Material and Methods section, mtDNA Mut cells exhibit decreased ATP synthesis
and respiration. We hypothesized that as a result of this severely compromised energy deficit
the concentrations of CoA and acetyl-CoA would also be severely compromised in the Mut cells.
This hypothesis was shown to be correct (Table 1). The concentrations of CoA and acetyl-CoA in
the cell extracts were measured (n = 6 for each group). Representative averages of experiments are
shown in Table 1. In all cases, the concentrations of CoA were found to be at least ten fold greater in
the WT cells than in the Mut cells (Table 1; p < 0.001). The concentration of acetyl-CoA in the Mut
cells was also lower than that in the WT cells. However, in this case the difference in the concentration
of acetyl-CoA between these two cell lines was only about 15–20%, but the difference is still highly
significant (Table 1; p < 0.005).
4.2. Rat Liver and Kidney
We have compared the concentration values for CoA and acetyl-CoA in rat liver and kidney
obtained by the present procedure to representative literature values (Table 2, [21,27]). Note that
methods to measure CoA and acetyl-CoA compiled by Bergmeyer [27] predate 1974—a time when
metabolites were often measured by enzymatic procedures. Indeed, measurements of acetyl-CoA and
CoA during this period were commonly carried out either by direct spectrophotometric measurement
of an enzyme product, or by an amplification enzyme cycling method [6,13,28]. It is interesting to note
that these methods yielded values of mammalian liver CoA and acetyl-CoA concentrations that are
very similar to values obtained by modern HPLC procedures (discussed further below). Note also
that in Table 1 we report these concentrations in terms of nmol/mg of protein. However, most
concentrations of CoA and acetyl-CoA reported in the literature are in units of µmol/g wet weight
(or nmol/g wet weight). Thus, assuming that 1 g wet weight of tissue contains 100 mg protein [29],
then the concentrations of CoA and acetyl-CoA in rat liver (from Table 1) are ~87 and ~19 nmol/g
wet weight. These values are in good agreement with representative, previously published data for
rat liver (Table 2). The concentrations of CoA and acetyl-CoA have also been measured in mouse
liver. The concentrations were reported to be ~160 and 105 nmol/g wet weight, respectively [30].
Thus, the concentration of CoA in mouse liver is similar to that noted by several authors for rat liver
(see Table 2). However, the concentration acetyl-CoA is considerably higher in mouse liver than that
reported for rat liver (Table 2). This may be due in part to species differences. The concentration of
acetyl-CoA in cow liver has been reported to be ~34 nmol/g wet weight [31]. The concentrations of
acetyl-CoA and CoA in sheep liver have been reported to be ~50 nmol/g wet weight [28]. In conclusion,
the concentration of hepatic CoA seems to be remarkably constant among the four mammalian species
(~50–160 nmol/g wet weight). The concentration of hepatic acetyl-CoA among these species is
somewhat more variable (19–105 nmol/g wet weight).
Table 2. Comparison of CoA and acetyl-CoA concentrations (nmol/g wet weight) in rat liver and
kidney from various literature sources.
Bergmeyer [27] a

Shibata et al. [21] N = 5

Present Findings b N = 16

Liver

Kidney

Liver

Kidney

Liver

Kidney

CoA

135–158

68

161

68

87.2 ± 12.2
(63–124)

19.1 ± 6.2
(8–31)

Acetyl-CoA

22–47

18–43

9

5

19.4 ± 3.8
(10–35)

1.30 ± 0.60
(0.2–3.6)

a The data are a compilation of several references. See Bergmeyer [27] for the original references. b The average
values are from Table 1 assuming that 1 g wet weight of tissue contains 100 mg of protein. The numbers in
parentheses represent the range of values from minimum to maximum.
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By using the same assumption that 1 g wet weight of tissue contains 100 mg of protein, the average
concentrations of CoA and acetyl-CoA in rat kidney (from Table 1) obtained by the present procedure
are ~19 and 1.3 nmol/g wet weight (Table 2). These concentrations are somewhat lower than
those reported by Shibata et al. [21] and by Bergmeyer [27]. This variability may be due in part
to the nutritional state of the experimental animal, whether or not the experimental animal was
exposed to an anesthetic, and/or time between sacrifice and tissue extraction. In this context, we note
that acetyl-CoA concentrations have been reported to be 2–6 fold higher in the livers of 24–48 h starved
rats than in the livers of fed rats [27], but others have found no change in the concentration of rat liver
acetyl-CoA after 24 h starvation [32].
4.3. Rat Plasma
We were unable to find values for plasma concentrations of CoA and acetyl-CoA in the scientific
literature. The concentration of CoA (~9 nM) and acetyl CoA (~0.3 nM) in the plasma of female Wistar
rats (4 month old; 130–140 g) (Table 1) is relatively low, emphasizing the sensitivity of the present
HPLC method. The present work apparently provides the first estimates of the concentration of
both CoA and acetyl-CoA in plasma. It is suggested that the procedure will be useful in correlating
the plasma concentration of these compounds with various disease states.
4.4. Rodent Brain
Measurement of metabolites in the rodent brain is challenging. During the time it takes to remove
the brain from the skull, the tissue will be subjected to anoxia/ischemia which may dramatically
affect metabolite concentrations, especially metabolites (including energy metabolites) that turn over
rapidly. For example, more than 50 years ago Lowry et al. [33] showed that within tens of seconds
following decapitation there is substantial loss of glucose, and a considerable increase in lactate in
mouse brain. Since the production of acetyl-CoA and CoA are intimately associated with energy
metabolism it is possible that these metabolites will also be altered in the ischemic brain. Kato [34]
noted a slight decrease in the concentration of whole mouse brain acetyl-CoA within 10–20 s of
decapitation, followed by a return to baseline levels by 30 s. In the study of McDougal and Dargar
the concentration of acetyl-CoA in mouse cerebral cortex decreased slightly after one minute of
anoxia/ischemia [14]. However, in later work Říčný and Tuček [11] investigated the effect of short
periods of anoxia/ischemia on the concentration of acetyl-CoA in brain tissue from 3-day-old rats, and
found that following decapitation the concentration of cerebral acetyl-CoA increased within a minute
by about 2.7 fold, when compared to that obtained for brain “fixed” almost immediately in live rats by
microwave irradiation [11]. The baseline concentration of acetyl-CoA obtained by Říčný and Tuček for
rat brain fixed by microwave irradiation was found to be ~1.9 nmol/g wet weight [11]. This value is
lower than that obtained by Allred and Guy [13] for a whole brain of ~8 nmol/g wet weight for adult,
fed rats (however, these authors did not specify how the brain was extracted.) In the present work
we noted a concentration of acetyl-CoA in the whole rat brain of ~0.028 nmol/mg protein (Table 1).
Assuming that 1 g of brain contains 100 mg protein [29,35], then the concentrations of CoA and
acetyl-CoA in rat brain by the present HPLC method are ~8 and ~2.8 nmol/g wet weight, respectively.
The present value for the cerebral concentration of CoA (~8 nmol/g wet weight) in adult rat brain is
within the range (~23 nmol/g wet weight) noted by Allred and Guy for young rats [13]. The present
value for the cerebral concentration of acetyl-CoA in rat brain (~2.8 nmol/g wet weight) is within
the range noted above as reported by Říčný and Tuček [11], and Allred and Guy [13] of ~1.9 and
~8 nmol/g wet weight, respectively.
We are aware that our procedure for measuring CoA and acetyl-CoA in rat brain involves
a step that subjects the brain to a short period of anoxia/ischemia. Thus, the present values for
the concentration of CoA and acetyl-CoA in rat brain are tentative. Nevertheless, the values are in
reasonable agreement with literature values, and suggest that our present method would be useful as
a general procedure for measuring CoA and acetyl-CoA in rodent brain.

Molecules 2017, 22, 1388

11 of 13

In addition to determining CoA and acetyl-CoA in rat brain, we determined the concentration of
these metabolites in mouse cortex, obtained from both WT and Mut mice. As noted above, the Mut
mice express a mutated form of mtDNA Polg that results in mtDNA with a higher burden of somatic
mutations. These damaged mitochondria are likely to be less effective in energy metabolism. As shown
in Table 1, the concentrations of both CoA and acetyl-CoA in cerebral cortex were found to be somewhat
lower in Mut mice when compared to those of WT mice. The observed trend in the differences
(~20% and 40% decrease in CoA and acetyl-CoA concentrations, respectively) is not statistically
significant due to a very high biological variability in mice compared to those noted for WT and
Mut cells in culture, where the data are much less variable (p < 0.001 and p < 0.005 for CoA and
acetyl-CoA, respectively) (Table 1). Again, we acknowledge the possible pitfalls in measuring CoA
and acetyl-CoA concentrations in the cerebral cortex obtained from ischemic/anoxic mouse brain.
Nevertheless, the data suggests that there is a trend toward lower values for the concentrations of CoA
and acetyl-CoA in the cerebral cortex of the Mut mice when compared to those in the cerebral cortex of
the WT mice. Note that the concentrations of CoA and acetyl-CoA in tissues depends on a number
of factors, such as how the rodent was sacrificed, the diet, fed or fasted state, and possibly, whether
or not the experimental animal was exposed to anesthesia (and what type of anesthesia). Moreover,
the presence/absence of mitochondrial mutations, the activity of PanK isoforms, and their localization
in different cell compartments and organs are also expected to contribute to the differences in tissue
concentrations of CoA and acetyl-CoA. As noted in the Introduction, PanK is an important factor in
tissue-selective CoA distribution [1–9,36–38].
5. Conclusions
The present work describes a rapid HPLC method for the determination of CoA and acetyl-CoA
in biological samples that is simpler and at least ten-fold more sensitive than are previously described
HPLC procedures. The current HPLC procedure was shown to be sensitive enough to provide reliable
estimates of the concentrations of CoA and acetyl-CoA in rat plasma despite concentrations in the nM
to sub nM range. Moreover, the present procedure allowed us to determine the concentration of these
biochemicals in very small samples (2–9 mg wet weight) of mouse brain cortex. To illustrate the general
usefulness of the procedure, we measured CoA and acetyl-CoA in WT osteosarcoma 143B cells, and in
the corresponding Mut rho0 cells. As expected, the concentrations of CoA and acetyl-CoA were found
to be significantly lower in the Mut rho0 cells. A similar observation was made for the concentration
of CoA and acetyl-CoA in the cerebral cortex of WT vs. Mut mtDNA Polg mice. The concentration of
these metabolites in normal rat liver, kidney, and brain, obtained by the present HPLC procedure are
in reasonable agreement with values in the literature.
It is expected that the present procedure will be useful for determining concentrations of CoA
and acetyl-CoA in a variety of biological materials and in tissues of animal models of human disease.
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